Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Suppan, C; Balic, M.
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer The best of ASCO 2019
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00530-x [OPEN ACCESS]
Web of Science FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Balic Marija
Suppan Christoph

Dimensions Citations:
Plum Analytics:

Scite (citation analytics):

Early stage HER2-positive cancer outcomes have been substantially improved over the last two decades, but there is still some potential for improvement. Several studies on the preoperative/postoperative treatment of HER2-positive breast cancer were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting.

Find related publications in this database (Keywords)
Breast cancer
Adjuvant treatment
© Med Uni Graz Impressum